Activation of Keap1/Nrf2 signaling manifests advantageous effects in a several disease states including diabetes, atherosclerosis, malaria, liver injury, obesity, neurodegenerative diseases, and certain cancers [39]. This evidence concerns the gene KEAP1 and obesity due to melanocortin 4 receptor deficiency.